Literature DB >> 11720881

Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies.

H F Escobar-Morreale1, M Asunción, R M Calvo, J Sancho, J L San Millán.   

Abstract

OBJECTIVE: We have used receiver operating characteristic (ROC) analysis to determine the diagnostic performance of several serum parameters, in order to evaluate their potential usefulness in establishing the diagnosis of polycystic ovary syndrome (PCOS) in epidemiological studies.
DESIGN: Prospective study.
METHODS: One hundred and fourteen women reporting spontaneously for blood donation were included in the study. Menopausal and oral contraceptive-treated women were excluded. Serum samples were obtained at the moment of donation, independently of fasting, time of day or day of menstrual cycle. Measurements included total testosterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), LH, FSH and estradiol. The free testosterone (FT) concentration and the free androgen index (FAI) were calculated from testosterone and SHBG levels. ROC curves were calculated for all these serum determinations.
RESULTS: Eight patients were diagnosed with PCOS, according to the presence of oligomenorrhea, hirsutism, acne and/or hyperandrogenemia, and exclusion of non-classic congenital adrenal hyperplasia, hypothyroidism and hyperprolactinemia. Of the parameters studied SHBG, FAI, FT and DHEAS were considered adequate measures for the diagnosis of PCOS. For example, serum SHBG levels showed an area under the ROC curve of 0.875+/-(S.E.(w))0.045 (95% confidence interval 0.800-0.929). A SHBG decision threshold <37 nmol/l had a sensitivity of 87.5%, a specificity of 86.8%, a positive likelihood ratio of 6.63, and a negative likelihood ratio of 0.14, for the diagnosis of PCOS.
CONCLUSIONS: Our present results strongly suggest that decreased SHBG levels, and increased FAI, free testosterone concentration and DHEAS concentrations, are highly effective as single analytical procedures in epidemiological studies for the detection of PCOS in women of reproductive age.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720881     DOI: 10.1530/eje.0.1450619

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  14 in total

1.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

2.  Grid analysis improves reliability in follicle counts made by ultrasonography in women with polycystic ovary syndrome.

Authors:  Marla E Lujan; Eric D Brooks; Anna L Kepley; Donna R Chizen; Roger A Pierson; Andrew K Peppin
Journal:  Ultrasound Med Biol       Date:  2010-04-09       Impact factor: 2.998

3.  Association of VDBP and CYP2R1 gene polymorphisms with vitamin D status in women with polycystic ovarian syndrome: a north Indian study.

Authors:  Deepa Haldar; Nitin Agrawal; Seema Patel; Pankaj Ramrao Kambale; Kanchan Arora; Aditi Sharma; Manish Tripathi; Aruna Batra; Bhaskar C Kabi
Journal:  Eur J Nutr       Date:  2016-12-23       Impact factor: 5.614

4.  A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells.

Authors:  Fan Qu; Fang-Fang Wang; Rong Yin; Guo-Lian Ding; Mohamed El-Prince; Qian Gao; Bi-Wei Shi; Hui-Hui Pan; Yi-Ting Huang; Min Jin; Peter C K Leung; Jian-Zhong Sheng; He-Feng Huang
Journal:  J Mol Med (Berl)       Date:  2012-02-21       Impact factor: 4.599

5.  Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.

Authors:  Flaminia Fanelli; Alessandra Gambineri; Marco Mezzullo; Valentina Vicennati; Carla Pelusi; Renato Pasquali; Uberto Pagotto
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 6.  Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies.

Authors:  Marla E Lujan; Donna R Chizen; Roger A Pierson
Journal:  J Obstet Gynaecol Can       Date:  2008-08

7.  Transcutaneous electrical acupoint stimulation alleviates the hyperandrogenism of polycystic ovarian syndrome rats by regulating the expression of P450arom and CTGF in the ovaries.

Authors:  Fan Qu; Yi Liang; Jue Zhou; Rui-Jie Ma; Jie Zhou; Fang-Fang Wang; Yan Wu; Jian-Qiao Fang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria.

Authors:  Andy Huang; Kathleen Brennan; Ricardo Azziz
Journal:  Fertil Steril       Date:  2009-02-26       Impact factor: 7.329

9.  Head-To-Head Assessment of Diagnostic Performance of Testosterone Immunoassays in Patients With Polycystic Ovary Syndrome.

Authors:  Andreas N Schüring; Stefan Nolte; Manfred Fobker; Frank Kannenberg; Jerzy-Roch Nofer
Journal:  J Clin Lab Anal       Date:  2015-10-26       Impact factor: 2.352

10.  Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement.

Authors:  Marla E Lujan; Donna R Chizen; Andrew K Peppin; Anita Dhir; Roger A Pierson
Journal:  J Ovarian Res       Date:  2009-06-10       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.